- Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
-
Casado E, Borque-Fernando A, Caamaño M, Graña J, Muñoz-Rodríguez J, Morote J
- KMID: 2523638
- World J Mens Health.
- 2022 Jan;40(1):74-86.
- doi: 10.5534/wjmh.210061
Patients with prostate cancer (PCa) on androgen-deprivation therapy (ADT) are at high risk of osteoporosis and fragility fractures. We aimed to provide some practical insights into the delivery of optimal... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
-
Morote J, Campistol M, Celma A, Regis L, Torres Id, Semidey ME, Roche S, Mast R, Santamaría A, Planas J, Trilla E
- KMID: 2527325
- World J Mens Health.
- 2022 Apr;40(2):270-279.
- doi: 10.5534/wjmh.210117
Purpose: To analyze how Proclarix is valuable to appropriately select candidates for multiparametric magnetic resonance imaging (mpMRI) and derived biopsies, among men with suspected prostate cancer (PCa). Proclarix is a... -
- CITED
-
- Close
- SHARE
-
- Close
